ClinicalTrials.Veeva

Menu

Combination of Nitrous Oxide 70% With Fentanyl Intranasal for Procedural Analgosedation in Children

University of Zurich (UZH) logo

University of Zurich (UZH)

Status and phase

Completed
Phase 3

Conditions

Opioid Analgesic Adverse Reaction
Pain
Inhalation of Nitrous Oxide

Treatments

Drug: Fentanyl intranasal
Drug: NaCl 0.9% intranasal

Study type

Interventional

Funder types

Other

Identifiers

NCT02533908
Fentanyl-2015

Details and patient eligibility

About

This study analyzes the analgesic efficacy and adverse events of nitrous oxide 70% combined with basic analgetics compared to nitrous oxide 70% with fentanyl intranasal for analgosedation for short and painful procedures in children.

Full description

Nitrous oxide 70% (N20 70%) combined with 30% oxygen meets many criteria of an ideal pain medication for procedural analgosedation in children. At the emergency department of the Children's Hospital of Zurich, Switzerland, N20 70% is regularly used for short and painful orthopaedic procedures, mostly for reduction of dislocated forearm or finger fractures. The analgesic efficacy of N20 70% still remains controversial. Therefore, all children who are eligible for N20 70% receive additionally either fentanyl or placebo intranasal and then their behavior, level of sedation and adverse events are measured during the painful procedure. The hypothesis is that a combination of N20 70% and fentanyl intranasal is not significant better than N20 70% combined with basic analgetics.

Enrollment

402 patients

Sex

All

Ages

2 to 16 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • indication for nitrous oxide 70% application
  • boys/girls aged 2-16 years
  • informed consent

Exclusion criteria

  • due to language barrier no sufficient communication possible to explain the study
  • incompatibility to Fentanyl Sintetica
  • incompatibility to morphinomimetics

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Quadruple Blind

402 participants in 2 patient groups, including a placebo group

Fentanyl intranasal
Active Comparator group
Description:
Fentanyl Sintetica 0.1mg/2ml: 1.5ug/kilogram intranasal= 0.03ml/kg once
Treatment:
Drug: Fentanyl intranasal
NaCl 0.9% intranasal
Placebo Comparator group
Description:
NaCl 0.9% Sintetica 18mg/2ml: same dosage as fentanyl= 0.03ml/kg
Treatment:
Drug: NaCl 0.9% intranasal

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems